Vortioxetine vs placebo in major depressive disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled, phase 3 trials in Japan

Psychiatry Clin Neurosci. 2020 May;74(5):330-332. doi: 10.1111/pcn.13001. Epub 2020 Apr 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Depressive Disorder, Major*
  • Double-Blind Method
  • Humans
  • Japan
  • Selective Serotonin Reuptake Inhibitors
  • Vortioxetine*

Substances

  • Serotonin Uptake Inhibitors
  • Vortioxetine